Financial hardship common among colon cancer patients

Financial hardship common among colon cancer patients

(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March 12 in the Journal of Clinical Oncology.

Veena Shankaran, M.D., of the University of Washington in Seattle, and colleagues conducted a study involving 555 patients with stage III , during or following adjuvant chemotherapy, who were identified using data from a population-based cancer registry. In an effort to identify those who experienced financial hardship as a direct result of their illness, participants completed a survey detailing their treatment-related costs, accrued debt, whether they were forced to sell assets or borrow money, or if they had experienced a decline in income.

The researchers found that nearly all of the 51.2 percent of patients who responded were insured during their colon cancer treatment. Overall, 38 percent reported some type of financial hardship as a consequence of their cancer treatment. Younger people and those with lower annual household incomes were more likely to report financial hardship. The factors most closely associated with treatment non-adherence were younger age, lower income, and unemployment or disability (which usually occurred following diagnosis).

"A significant proportion of patients undergoing adjuvant chemotherapy for stage III colon cancer may experience , despite having . Interventions to help at-risk patients early on during therapy may prevent long-term financial adverse effects," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

add to favorites email to friend print save as pdf

Related Stories

Gene signature may improve colon cancer treatment

Feb 26, 2010

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

Recommended for you

Generation of tanners see spike in deadly melanoma

11 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

11 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Cancer: Tumors absorb sugar for mobility

23 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

User comments